Envista Holdings Corporation

NVST · NYSE · Stock · Healthcare
$22.82
+0.75% today
Delayed price,

What Envista Holdings does

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$3.67B
P/E (ttm)
39.3
Forward P/E
13.7
Dividend yield
0.00%
Beta
0.89
Profit margin
3.3%
Employees
12,000
Headquarters
Brea, CA, United States
Exchange
NYSE

Performance

1 Month
-2.3%
3 Months
-14.7%
6 Months
-18.0%
1 Year
+14.3%
5 Years
-41.2%
$18.7752-week range$30.42
Biggest setback — last 12 months
-22.5%
23 Feb 2026 → 12 Oct 2026
Fell from $29.21 to $22.65 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+50.6%
10 Nov 2025 → 23 Feb 2026
Ran from $19.40 to $29.21 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend
Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$20.56 (-9.2%)$22.65$24.95 (+10.2%)
3 Months$19.16 (-15.4%)$22.65$26.78 (+18.2%)
6 Months$17.87 (-21.1%)$22.65$28.71 (+26.7%)
12 Months$16.20 (-28.5%)$22.65$31.67 (+39.8%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 33.5%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.